Signal amplification and output of CRISPR/Cas-based biosensing systems: A review

• Published in: Analytica chimica acta 2021-11, Vol.1185, p.338882-338882, Article 338882
• Main Authors: Wang, Si-Yuan, Du, Yi-Chen, Wang, Dong-Xia, Ma, Jia-Yi, Tang, An-Na, Kong, De-Ming
• Format: Article
• Language: English
• Subjects: Biosensing; CRISPR/Cas; Signal amplification; Signal output
• ISSN: 0003-2670; 1873-4324
• DOI: 10.1016/j.aca.2021.338882

CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) proteins are powerful gene-editing tools because of their ability to accurately recognize and manipulate nucleic acids. Besides gene-editing function, they also show great promise in biosensing applications due to the superiority of easy design and precise targeting. To improve the performance of CRISPR/Cas-based biosensing systems, various nucleic acid-based signal amplification techniques are elaborately incorporated. The incorporation of these amplification techniques not only greatly increases the detection sensitivity and specificity, but also extends the detectable target range, as well as makes the use of various signal output modes possible. Therefore, summarizing the use of signal amplification techniques in sensing systems and elucidating their roles in improving sensing performance are very necessary for the development of more superior CRISPR/Cas-based biosensors for various applications. In this review, CRISPR/Cas-based biosensors are summarized from two aspects: the incorporation of signal amplification techniques in three kinds of CRISPR/Cas-based biosensing systems (Cas9, Cas12 and Cas13-based ones) and the signal output modes used by these biosensors. The challenges and prospects for the future development of CRISPR/Cas-based biosensors are also discussed. [Display omitted] •The breakthrough achievements of CRISPR/Cas-based biosensors are reviewed.•The incorporation of signal amplification techniques in CRISPR/Cas-based biosensors are summarized.•The signal output modes used by CRISPR/Cas-based biosensors are introduced.•The challenges and prospects for the future development of CRISPR/Cas-based biosensors are discussed.